Humana Inc. (HUM) EV/EBITDA Ratio: 18.61x
Is Humana Inc.’s EV/EBITDA ratio high or low?
Humana Inc.'s EV/EBITDA ratio of 18.61x is 51% above its 5-year average of 12.36x, near the high end of its 5-year range (7.80x–18.61x).
The EV/EBITDA ratio for Humana Inc. (HUM) is 18.61x as of Wednesday, June 10, 2026. It is above its 12-month average by 59.31% (11.68x).
HUM EV/EBITDA Ratio Chart
HUM Average EV/EBITDA Ratio Chart
HUM Current vs Average EV/EBITDA Ratio Chart
HUM EV/EBITDA Ratio Metrics
EV/EBITDA RATIO
18.61x
EV/EBITDA RATIO AVG TTM
11.68x
EV/EBITDA RATIO AVG 3Y
11.33x
EV/EBITDA RATIO AVG 5Y
12.36x
EV/EBITDA RATIO AVG 10Y
11.94x
EV/EBITDA RATIO AVG 15Y
10.31x
EV/EBITDA RATIO AVG 20Y
9.37x
CURRENT VS TTM AVG
+59.31%
CURRENT VS 3Y AVG
+64.23%
CURRENT VS 5Y AVG
+50.54%
CURRENT VS 10Y AVG
+55.85%
CURRENT VS 15Y AVG
+80.44%
CURRENT VS 20Y AVG
+98.53%
HUM Competitors' EV/EBITDA Ratio
| NAME | MARKET CAP | EV/EBITDA RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Humana Inc. (HUM) | $43.78B | 18.61x | 11.68x | 11.33x | 12.36x |
| IDEXX Laboratories, Inc. (IDXX) | $44.47B | 30.48x | 35.75x | 34.46x | 38.26x |
| Agilent Technologies, Inc. (A) | $37.17B | 20.92x | 21.12x | 21.69x | 23.11x |
| Zoetis Inc. (ZTS) | $34.20B | 10.33x | 15.67x | 20.68x | 23.76x |
| Centene Corporation (CNC) | $31.94B | N/A | 4.99x | 7.28x | 9.49x |
| Medline Inc. (MDLN) | $30.90B | 13.75x | 15.00x | 15.00x | 15.00x |
| IQVIA Holdings Inc. (IQV) | $30.60B | 8.90x | 13.19x | 14.98x | 17.09x |
| DexCom, Inc. (DXCM) | $29.24B | 23.24x | 28.10x | 43.48x | 70.03x |
| Biogen Inc. (BIIB) | $29.00B | 11.60x | 8.56x | 11.16x | 12.22x |
| Veeva Systems Inc. (VEEV) | $26.73B | 25.37x | 43.29x | 56.90x | 62.37x |
EV/EBITDA vs. its own history
At 18.6, EV/EBITDA is richer than usual — richer than 99% of its 20-year range.
20-year low
2.6
median
9.5
20-year high
20.5
Understanding EV/EBITDA
Enterprise Value (EV) = Market Cap + Total Debt - Cash
EBITDA = Earnings Before Interest, Taxes, Depreciation & Amortization
EV/EBITDA is commonly used for comparing companies because:
- It accounts for debt levels (capital structure neutral)
- It removes effects of different depreciation policies
- It can be compared across countries with different tax rates
- It can remain available when net income is negative, if EBITDA is positive
Humana Inc. EV/EBITDA Ratio Formula & Definition
EV/EBITDA = Enterprise Value / EBITDA (TTM)
Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Humana Inc. EV/EBITDA Ratio FAQ
- What is the EV/EBITDA ratio for Humana Inc. (HUM)?
- The EV/EBITDA ratio for HUM stock is 18.61x.
- Is Humana Inc.'s EV/EBITDA ratio high or low?
- Humana Inc.'s EV/EBITDA ratio of 18.61x is 51% above its 5-year average of 12.36x, near the high end of its 5-year range (7.80x–18.61x).
- What is the TTM average EV/EBITDA ratio for Humana Inc. (HUM)?
- The TTM average EV/EBITDA ratio for HUM stock is 11.68x.
- What is the 3Y average EV/EBITDA ratio for Humana Inc. (HUM)?
- The 3Y average EV/EBITDA ratio for HUM stock is 11.33x.
- What is the 5Y average EV/EBITDA ratio for Humana Inc. (HUM)?
- The 5Y average EV/EBITDA ratio for HUM stock is 12.36x.
- What is the 10Y average EV/EBITDA ratio for Humana Inc. (HUM)?
- The 10Y average EV/EBITDA ratio for HUM stock is 11.94x.
- What is the 15Y average EV/EBITDA ratio for Humana Inc. (HUM)?
- The 15Y average EV/EBITDA ratio for HUM stock is 10.31x.
- What is the 20Y average EV/EBITDA ratio for Humana Inc. (HUM)?
- The 20Y average EV/EBITDA ratio for HUM stock is 9.37x.
Humana Inc. EV/EBITDA Ratio History
| DATE | EV/EBITDA RATIO |
|---|---|
| 2026-06-10 | 18.61x |
| 2026-06-09 | 18.54x |
| 2026-06-08 | 18.24x |
| 2026-06-05 | 17.99x |
| 2026-06-04 | 17.97x |
| 2026-06-03 | 17.03x |
| 2026-06-02 | 16.75x |
| 2026-06-01 | 17.07x |
| 2026-05-29 | 16.10x |
| 2026-05-28 | 16.24x |
| 2026-05-27 | 16.13x |
| 2026-05-26 | 15.94x |
| 2026-05-22 | 16.20x |
| 2026-05-21 | 16.02x |
| 2026-05-20 | 16.04x |
| 2026-05-19 | 16.31x |
| 2026-05-18 | 16.12x |
| 2026-05-15 | 16.08x |
| 2026-05-14 | 15.92x |
| 2026-05-13 | 16.07x |
| 2026-05-12 | 15.67x |
| 2026-05-11 | 14.78x |
| 2026-05-08 | 14.81x |
| 2026-05-07 | 13.63x |
| 2026-05-06 | 13.60x |
| 2026-05-05 | 13.31x |
| 2026-05-04 | 13.24x |
| 2026-05-01 | 13.06x |
| 2026-04-30 | 13.18x |
| 2026-04-29 | 13.46x |
| 2026-04-28 | 12.51x |
| 2026-04-27 | 12.27x |
| 2026-04-24 | 11.91x |
| 2026-04-23 | 11.90x |
| 2026-04-22 | 12.00x |
| 2026-04-21 | 12.00x |
| 2026-04-20 | 11.71x |
| 2026-04-17 | 11.49x |
| 2026-04-16 | 11.31x |
| 2026-04-15 | 11.21x |
| 2026-04-14 | 11.12x |
| 2026-04-13 | 11.21x |
| 2026-04-10 | 10.96x |
| 2026-04-09 | 11.17x |
| 2026-04-08 | 11.21x |
| 2026-04-07 | 11.16x |
| 2026-04-06 | 10.56x |
| 2026-04-02 | 10.36x |
| 2026-04-01 | 10.33x |
| 2026-03-31 | 10.18x |
| 2026-03-30 | 9.87x |
| 2026-03-27 | 10.00x |
| 2026-03-26 | 10.25x |
| 2026-03-25 | 10.21x |
| 2026-03-24 | 10.13x |
| 2026-03-23 | 10.05x |
| 2026-03-20 | 10.04x |
| 2026-03-19 | 9.89x |
| 2026-03-18 | 10.06x |
| 2026-03-17 | 10.07x |
| 2026-03-16 | 10.04x |
| 2026-03-13 | 9.85x |
| 2026-03-12 | 9.78x |
| 2026-03-11 | 10.08x |
| 2026-03-10 | 10.19x |
| 2026-03-09 | 10.39x |
| 2026-03-06 | 10.42x |
| 2026-03-05 | 10.48x |
| 2026-03-04 | 10.58x |
| 2026-03-03 | 10.52x |
| 2026-03-02 | 10.75x |
| 2026-02-27 | 10.89x |
| 2026-02-26 | 10.74x |
| 2026-02-25 | 10.29x |
| 2026-02-24 | 10.23x |
| 2026-02-23 | 10.50x |
| 2026-02-20 | 10.86x |
| 2026-02-19 | 10.89x |
| 2026-02-18 | 9.63x |
| 2026-02-17 | 9.54x |
| 2026-02-13 | 9.51x |
| 2026-02-12 | 9.30x |
| 2026-02-11 | 9.17x |
| 2026-02-10 | 9.40x |
| 2026-02-09 | 9.72x |
| 2026-02-06 | 9.89x |
| 2026-02-05 | 9.88x |
| 2026-02-04 | 9.82x |
| 2026-02-03 | 9.86x |
| 2026-02-02 | 9.63x |
| 2026-01-30 | 9.94x |
| 2026-01-29 | 10.00x |
| 2026-01-28 | 9.89x |
| 2026-01-27 | 10.44x |
| 2026-01-26 | 12.61x |
| 2026-01-23 | 12.72x |
| 2026-01-22 | 12.71x |
| 2026-01-21 | 12.88x |
| 2026-01-20 | 12.78x |
| 2026-01-16 | 12.98x |
| 2026-01-15 | 13.40x |
| 2026-01-14 | 13.02x |
| 2026-01-13 | 13.01x |
| 2026-01-12 | 13.11x |
| 2026-01-09 | 13.12x |
| 2026-01-08 | 13.15x |
| 2026-01-07 | 13.05x |
| 2026-01-06 | 13.24x |
| 2026-01-05 | 13.08x |
| 2026-01-02 | 12.64x |
| 2025-12-31 | 12.32x |
| 2025-12-30 | 12.43x |
| 2025-12-29 | 12.40x |
| 2025-12-26 | 12.42x |
| 2025-12-24 | 12.44x |
| 2025-12-23 | 12.35x |
| 2025-12-22 | 12.38x |
| 2025-12-19 | 12.44x |
| 2025-12-18 | 12.49x |
| 2025-12-17 | 12.48x |
| 2025-12-16 | 12.39x |
| 2025-12-15 | 13.04x |
| 2025-12-12 | 12.80x |
| 2025-12-11 | 12.72x |
| 2025-12-10 | 12.34x |
| 2025-12-09 | 12.09x |
| 2025-12-08 | 12.33x |
| 2025-12-05 | 12.38x |
| 2025-12-04 | 12.19x |
| 2025-12-03 | 12.35x |
| 2025-12-02 | 11.76x |
| 2025-12-01 | 11.77x |
| 2025-11-28 | 11.91x |
| 2025-11-26 | 11.92x |
| 2025-11-25 | 11.60x |
| 2025-11-24 | 11.27x |
| 2025-11-21 | 11.18x |
| 2025-11-20 | 11.04x |
| 2025-11-19 | 11.25x |
| 2025-11-18 | 11.46x |
| 2025-11-17 | 11.46x |
| 2025-11-14 | 11.57x |
| 2025-11-13 | 11.56x |
| 2025-11-12 | 11.71x |
| 2025-11-11 | 11.82x |
| 2025-11-10 | 11.63x |
| 2025-11-07 | 12.16x |
| 2025-11-06 | 12.12x |
| 2025-11-05 | 12.66x |
| 2025-11-04 | 11.62x |
| 2025-11-03 | 11.55x |
| 2025-10-31 | 11.50x |
| 2025-10-30 | 11.74x |
| 2025-10-29 | 11.97x |
| 2025-10-28 | 12.04x |
| 2025-10-27 | 11.96x |
| 2025-10-24 | 11.91x |
| 2025-10-23 | 11.93x |
| 2025-10-22 | 11.81x |
| 2025-10-21 | 12.06x |
| 2025-10-20 | 11.69x |
| 2025-10-17 | 11.39x |
| 2025-10-16 | 11.14x |
| 2025-10-15 | 10.97x |
| 2025-10-14 | 10.95x |
| 2025-10-13 | 11.26x |
| 2025-10-10 | 11.56x |
| 2025-10-09 | 11.91x |
| 2025-10-08 | 12.15x |
| 2025-10-07 | 12.06x |
| 2025-10-06 | 12.06x |
| 2025-10-03 | 11.68x |
| 2025-10-02 | 10.79x |
| 2025-10-01 | 10.46x |
| 2025-09-30 | 10.90x |
| 2025-09-29 | 10.74x |
| 2025-09-26 | 10.73x |
| 2025-09-25 | 10.71x |
| 2025-09-24 | 10.96x |
| 2025-09-23 | 10.84x |
| 2025-09-22 | 10.83x |
| 2025-09-19 | 10.66x |
| 2025-09-18 | 11.06x |
| 2025-09-17 | 11.21x |
| 2025-09-16 | 11.30x |
| 2025-09-15 | 11.41x |
| 2025-09-12 | 11.44x |
| 2025-09-11 | 11.51x |
| 2025-09-10 | 11.34x |
| 2025-09-09 | 11.33x |
| 2025-09-08 | 12.56x |
| 2025-09-05 | 12.48x |
| 2025-09-04 | 12.61x |
| 2025-09-03 | 12.61x |
| 2025-09-02 | 12.55x |
| 2025-08-29 | 12.34x |
| 2025-08-28 | 12.15x |
| 2025-08-27 | 12.13x |
| 2025-08-26 | 12.18x |
| 2025-08-25 | 12.12x |
| 2025-08-22 | 12.20x |
| 2025-08-21 | 12.03x |
| 2025-08-20 | 11.89x |
| 2025-08-19 | 11.83x |
| 2025-08-18 | 11.79x |
| 2025-08-15 | 11.77x |
| 2025-08-14 | 11.60x |
| 2025-08-13 | 11.62x |
| 2025-08-12 | 11.39x |
| 2025-08-11 | 11.12x |
| 2025-08-08 | 11.12x |
| 2025-08-07 | 10.77x |
| 2025-08-06 | 10.79x |
| 2025-08-05 | 10.72x |
| 2025-08-04 | 10.48x |
| 2025-08-01 | 10.48x |
| 2025-07-31 | 10.56x |
| 2025-07-30 | 10.95x |
| 2025-07-29 | 9.56x |
| 2025-07-28 | 9.52x |
| 2025-07-25 | 9.72x |
| 2025-07-24 | 9.45x |
| 2025-07-23 | 9.70x |
| 2025-07-22 | 9.51x |
| 2025-07-21 | 9.27x |
| 2025-07-18 | 9.18x |
| 2025-07-17 | 9.28x |
| 2025-07-16 | 9.37x |
| 2025-07-15 | 9.22x |
| 2025-07-14 | 9.40x |
| 2025-07-11 | 9.50x |
| 2025-07-10 | 9.54x |
| 2025-07-09 | 9.68x |
| 2025-07-08 | 9.71x |
| 2025-07-07 | 9.70x |
| 2025-07-03 | 9.78x |
| 2025-07-02 | 9.90x |
| 2025-07-01 | 10.18x |
| 2025-06-30 | 9.93x |
| 2025-06-27 | 9.84x |
| 2025-06-26 | 9.78x |
| 2025-06-25 | 9.74x |
| 2025-06-24 | 9.75x |
| 2025-06-23 | 9.62x |
| 2025-06-20 | 9.77x |
| 2025-06-18 | 9.89x |
| 2025-06-17 | 9.83x |
| 2025-06-16 | 9.64x |
| 2025-06-13 | 9.64x |
| 2025-06-12 | 9.63x |
| 2025-06-11 | 9.53x |
| 2025-06-10 | 9.54x |
| 2025-06-09 | 9.57x |
| 2025-06-06 | 9.50x |
| 2025-06-05 | 9.39x |
| 2025-06-04 | 9.50x |
| 2025-06-03 | 9.58x |
| 2025-06-02 | 9.52x |
| 2025-05-30 | 9.57x |
| 2025-05-29 | 9.48x |
Showing the most recent 260 of 5,031 data points. The chart above shows the full history.
Related Metrics
About Humana Inc.
Humana Inc., a prominent health and well-being enterprise, operates across the United States through its various subsidiary companies. Its operational structure is divided into three main segments: Retail, Group and Specialty, and Healthcare Services. The firm provides a wide array of medical and supplementary insurance plans directly to individual consumers. Furthermore, Humana collaborates with government entities; it holds a contract with the Centers for Medicare and Medicaid Services (CMS) to manage the Limited Income Newly Eligible Transition (LI NET) prescription drug program. The company also secures agreements with numerous states to deliver Medicaid, dual-eligible, and long-term care support benefits. For employer groups and individuals, Humana furnishes fully insured commercial medical and specialized health coverage, which encompasses dental, vision, and other ancillary health benefits. They additionally offer administrative services only (ASO) solutions and extend support to military personnel through contracts like the TRICARE T2017 East Region. Beyond insurance products, the company delivers comprehensive healthcare services directly. These include pharmacy management, provider network services, and a suite of home-based solutions such as home health care, serving both its own health plan enrollees and external clients. By the close of 2021 (December 31), Humana's reach extended to approximately 17 million individuals enrolled in its medical benefit plans and an additional 5 million utilizing its specialized product offerings. Established in 1961, Humana Inc. maintains its corporate headquarters in Louisville, Kentucky.
- Sector
- Healthcare
- Industry
- Medical - Healthcare Plans
- CEO
- James A. Rechtin